Navigation Links
Berg Pharma Presents Key Findings in Cancer Systems Biology and Mitochondrial Metabolism at AACR Meeting
Date:4/4/2012

CHICAGO, April 4, 2012 /PRNewswire/ -- Berg Pharma, a Boston based pharmaceutical company presented novel data today pertaining to key insights into cancer cell metabolism at the 103rd Annual AACR meeting.  The company had a total of 5 presentations at the meeting that dealt with endothelial cell biology relative to tumor angiogenesis, mitochondrial flux in cancer cells for priming of cancer therapy, synergy of BPM 31510, Berg's lead oncology drug in development with gemcitabine, and use of Interrogative Biology® for cancer systems biology. BPM 31510 is now in Phase I trials for advanced, refractory solid tumors and the company plans to commence Phase III trials with the topical form of the technology for squamous cell carcinoma this year.

(Logo:  http://photos.prnewswire.com/prnh/20120404/CL82745LOGO )

Seth Corey, MD, Director of the Center for Drug Development at Children's Memorial Research Center and the Robert H. Lurie Comprehensive Cancer Center at Northwestern University called the systems biology approach, "most revolutionary technology in medicine today." He added, "given what we know of tumor heterogeneity and complexity, the systems approach and cancer metabolism as the target together offer the surest path to more effective therapies."

The research team employed the Interrogative Biology® discovery platform which takes an agnostic approach to biological modeling where systems models with disease-relevant perturbations and microenvironments are subjected to AI-Bayesian algorithms.  The generated output then teases out disease-normal nodal signatures which reflect pathological pressure points.  These are then used to identify and validate biomarkers and therapeutic targets to expedite the drug development process. This novel approach from the Berg Interrogative Biology® technology pla
'/>"/>

SOURCE Berg Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... - Protecting the health and safety of Canadians is our government,s ... powers and tools at its disposal to help ensure that the ... To that end, Health Canada ... Canada of all drug products from three plants ... , Apotex Pharmachem India Pvt Ltd , Apotex Research ...
(Date:9/30/2014)... Sept. 30, 2014  Tasly Pharmaceuticals, Inc., the ... medicine, announced today the launch of Deepure. ... to address men and women concerned with supporting ... into old age while helping keep their health ... whole-food and herb-based formulas, namely, ProHeart PLUS, ImmunoPower ...
(Date:9/30/2014)... , Sept. 30, 2014  Decision Resources Group finds ... Brazil , Russia ... China (BRIC) will see robust expansion as ... favored over surgical procedures. Although revenues will be somewhat ... challenges, prolonged device approval times and demand for low-cost ...
Breaking Medicine Technology:Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3
(Date:10/2/2014)... Thompson HealthDay Reporter ... pull out all the stops to rescue surgical patients ... the cost of such heroism is questionable, a new ... percent better at saving elderly patients with life-threatening complications ... less intensity, said senior author Dr. Amir Ghaferi. He ...
(Date:10/1/2014)... more than 80 per cent of bowel cancers could ... that medicines called ,JAK inhibitors, halted tumour growth in ... in more than 80 per cent of bowel cancers. ... clinical trials, for diseases including rheumatoid arthritis, psoriasis, blood ... second-most common cancer in Australia with nearly 17,000 people ...
(Date:10/1/2014)... 2014) Despite a policy focus on expanding ... this vulnerable population continues to have significant dental ... Journal of the American Dental Association , researchers ... University School of Dental Medicine report on the ... oral care provided by caregivers to adults with ...
(Date:10/1/2014)... Bedros Keuilian is not only the founder ... camps, he’s also considered the leading expert on marketing ... business summits, a line of high-demand fitness marketing systems ... Spike TV reality show to his name. , With ... for personal trainers and fitness business owners to focus ...
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
Breaking Medicine News(10 mins):Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Farmington Company Launches Rebrand and New Positioning 2
... University School of Medicine will add several new pediatric clinical rotations ... , ... North Brunswick, NJ (PRWEB) February 11, 2009-- ... will add several new pediatric clinical rotations to its growing network ...
... DaVita Inc.,(NYSE: DVA ) today announced results for ... the three months ended December 31, 2008 was $98.4,million, or ... per share,for the same period of 2007. , ... Net income for the year ended December 31, ...
... today reported significantly higher sales and earnings for both its fiscal third quarter and ... , Third quarter revenue increases 16% ... , Third quarter diluted EPS increases ... quarter of fiscal 2009, net sales increased 16 percent to $5,337,000 from $4,614,000 in ...
... First-Time AttendeesSTOWE, Vt., Feb. 10 The 9th Annual ... Learning for Survivors of All Cancers, and Those Who Love ... Stowe, Vermont, opens registration on February 24th, 2009.The Stowe ... has become one of the most inspiring, educational and unprecedented ...
... 10 Allscripts-Misys Healthcare,Solutions, Inc. ("Allscripts") announced today that ... under which Allscripts may purchase up to,$150 million of ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ... pursuant to Rule 10b5-1 or 10b-18 of the,Securities Exchange ...
... brain, researchers say , , TUESDAY, Feb. 10 (HealthDay News) ... don,t even bother to use them because they,re difficult ... nerves are allowing the brain to communicate directly with ... a banana and fold laundry. , "In the simplest ...
Cached Medicine News:Health News:Ross University School of Medicine Expands Clinical Rotations at Miami Children's Hospital 2Health News:DaVita 4th Quarter 2008 Results 2Health News:DaVita 4th Quarter 2008 Results 3Health News:DaVita 4th Quarter 2008 Results 4Health News:DaVita 4th Quarter 2008 Results 5Health News:DaVita 4th Quarter 2008 Results 6Health News:DaVita 4th Quarter 2008 Results 7Health News:DaVita 4th Quarter 2008 Results 8Health News:DaVita 4th Quarter 2008 Results 9Health News:DaVita 4th Quarter 2008 Results 10Health News:DaVita 4th Quarter 2008 Results 11Health News:DaVita 4th Quarter 2008 Results 12Health News:DaVita 4th Quarter 2008 Results 13Health News:DaVita 4th Quarter 2008 Results 14Health News:DaVita 4th Quarter 2008 Results 15Health News:DaVita 4th Quarter 2008 Results 16Health News:DaVita 4th Quarter 2008 Results 17Health News:DaVita 4th Quarter 2008 Results 18Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:9th Annual Stowe Weekend of Hope Registration Opens February 24 2Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 2Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 3Health News:Allscripts Announces $150 Million Stock Repurchase Program and Increase in Credit Facility Commitments 4Health News:New Technology May Boost Artificial Arms 2
End-gripping forceps with small, concentric rings on each tip. For general purpose membrane grasping, particularly thin membranes, or grasping membranes adherent to the retinal surface....
... design and developmerit of systems for the ... is pleased to present its latest system ... in one compact system. The D.O.R.C. VFI/VFE ... such as silicone oil, with viscosities of ...
... The D.O.R.C. HEXON Illumination System ... Xenon systems offer, with one remarkable ... discharge lamp, a more efficient source ... illumination quality provides a color consistency ...
... The EndoProbe handpieces, used for ... active aspiration, 25 gauge, and illuminating ... provides the ophthalmologist with uncompromised laser ... have 3-meter, fiber-optic cables that are ...
Medicine Products: